Vaxcyte Overview
Vaxcyte Target Price
Analysts' 12-month price predictions for PCVX.
Get informed when a big investor buys or sells
+ FollowShare Price
$58.39
Average Target Price
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-02-25 | BTIGTom Shrader | $89 |  52.4% upside |  |
| 2025-11-19 | Leerink PartnersDavid Risinger | $77 | 31.9% upside | |
| 2024-11-06 | JefferiesRoger Song | $146 | 150% upside | |
| 2024-11-06 | Leerink PartnersDavid Risinger | $135 | 131.2% upside | |
| 2024-09-10 | Mizuho SecuritiesSalim Syed | $163 | 179.2% upside | |
| 2024-09-04 | Bank of America SecuritiesJason Gerberry | $140 | 139.8% upside | |
| 2024-09-03 | Leerink PartnersDavid Risinger | $153 | 162% upside | |
| 2024-09-03 | BTIGTom Shrader | $160 | 174% upside | |
| 2024-09-03 | JefferiesRoger Song | $129 | 120.9% upside | |
| 2024-09-03 | Mizuho SecuritiesSalim Syed | $113 | 93.5% upside | |
| 2024-08-07 | BTIGTom Shrader | $98 | 67.8% upside | |
| 2023-01-03 | Needham | $58 |  0.7% downside | |
| 2022-12-16 | Leerink Partners | $60 | 2.8% upside | |
| 2022-12-15 | Guggenheim | $66 | 13% upside | |
| 2022-11-17 | BTIG | $69 | 18.2% upside | |